The ANXA1-derived peptide MC-12 was used by Ouyang et al. (2012) as a NFκB inhibitor in mice with DSS-induced colitis and were able to restore cytokines TNFα, IFNγ, and IL1β, IL6, and IL10 to a baseline. The gene discussed is NFKB1; the disease is colitis.